全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

溃疡性结肠炎对帕金森病的影响:肠道炎症、屏障功能损伤与神经炎症的研究
Impact of Ulcerative Colitis on Parkinson’s Disease: A Study on Gut Inflammation, Barrier Dysfunction, and Neuroinflammation

DOI: 10.12677/acm.2025.152464, PP. 1210-1217

Keywords: 帕金森病,溃疡性结肠炎,肠–脑轴,肠道屏障,神经炎症
Parkinson’s Disease
, Ulcerative Colitis, Gut-Brain Axis, Gut Barrier, Neuroinflammation

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:本研究旨在探讨溃疡性结肠炎(Ulcerative Colitis, UC)是否通过肠道–脑轴机制加重帕金森病(Parkinson’s Disease, PD)的神经病理表现,并揭示肠道炎症及屏障损伤在其中的潜在作用机制。方法:将7周龄SPF级C57BL/6J雄性小鼠随机分为四组:对照组(CON组)、结肠炎组(DSS组)、PD模型组(MPTP组)、联合模型组(MPTP + DSS组),每组6只。小鼠适应性饲养一周后进行以下处理:CON组腹腔注射生理盐水5天并持续饲养生理盐水;DSS组腹腔注射生理盐水5天,饲养21天后用2.5%葡聚糖硫酸盐(DSS)溶液诱导结肠炎;MPTP组腹腔注射30 mg/kg 1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP) 5天并持续饲养28天以建立PD模型;MPTP + DSS组同样腹腔注射MPTP 5天,饲养21天后用2.5% DSS溶液诱导结肠炎。收集小鼠组织,利用高效液相色谱(HPLC)检测纹状体多巴胺(DA)水平;通过实时荧光定量PCR (RT-qPCR)检测结肠和黑质的炎症因子表达水平以及结肠紧密连接蛋白水平。结果:与MPTP组相比,MPTP + DSS组小鼠的纹状体DA水平显著降低(P < 0.05),黑质炎症因子(IL-1β, IL-6, IL-8, TNF-α)表达显著升高(P < 0.05)。结论:本研究表明,溃疡性结肠炎通过破坏肠道屏障并激活肠–脑轴的炎症反应,进一步降低了PD小鼠纹状体DA水平,并增加黑质炎症因子的表达,从而加重了PD小鼠的神经损伤。
Objective: This study aimed to investigate whether ulcerative colitis (UC) exacerbates the neuropathological features of Parkinson’s disease (PD) through the gut-brain axis and to explore the potential role of intestinal inflammation and barrier disruption in this process. Methods: Seven-week-old SPF-grade male C57BL/6J mice were randomly divided into four groups: control (CON), DSS-induced colitis (DSS), PD model (MPTP), and combined model (MPTP + DSS), with six mice in each group. After one week of adaptive feeding, the mice were treated as follows: the CON group received intraperitoneal injections of normal saline for 5 days and continued on a normal saline diet; the DSS group received intraperitoneal injections of normal saline for 5 days, followed by 2.5% dextran sulfate sodium (DSS) solution to induce colitis after 21 days of normal feeding; the MPTP group received intraperitoneal injections of 30 mg/kg 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) for 5 days and were fed normally for 28 days to establish a PD model; the MPTP + DSS group received MPTP injections for 5 days, followed by 2.5% DSS solution to induce colitis after 21 days of recovery. Tissue samples were collected, and striatal dopamine (DA) levels were measured using high-performance liquid chromatography (HPLC). Inflammatory cytokines in the colon and substantia nigra, as well as tight junction protein levels in the colon, were detected using real-time quantitative PCR (RT-qPCR). Results: Compared to the MPTP group, mice in the MPTP + DSS group exhibited significantly decreased striatal DA levels (P < 0.05) and significantly increased expression levels of inflammatory cytokines (IL-1β, IL-6, IL-8,

References

[1]  Hayes, M.T. (2019) Parkinson’s Disease and Parkinsonism. The American Journal of Medicine, 132, 802-807.
https://doi.org/10.1016/j.amjmed.2019.03.001
[2]  杜希恂, 姜宏. 帕金森病的研究进展[J]. 青岛大学学报(医学版), 2019, 55(1): 1-5, 9.
[3]  Sorboni, S.G., Moghaddam, H.S., Jafarzadeh-Esfehani, R. and Soleimanpour, S. (2022) A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders. Clinical Microbiology Reviews, 35, e33820.
https://doi.org/10.1128/cmr.00338-20
[4]  Kang, D., Adams, J.B., Gregory, A.C., Borody, T., Chittick, L., Fasano, A., et al. (2017) Microbiota Transfer Therapy Alters Gut Ecosystem and Improves Gastrointestinal and Autism Symptoms: An Open-Label Study. Microbiome, 5, Article No. 10.
https://doi.org/10.1186/s40168-016-0225-7
[5]  Le Berre, C., Honap, S. and Peyrin-Biroulet, L. (2023) Ulcerative Colitis. The Lancet, 402, 571-584.
https://doi.org/10.1016/s0140-6736(23)00966-2
[6]  Marchal-Bressenot, A., Salleron, J., Boulagnon-Rombi, C., Bastien, C., Cahn, V., Cadiot, G., et al. (2015) Development and Validation of the Nancy Histological Index for Uc. Gut, 66, 43-49.
https://doi.org/10.1136/gutjnl-2015-310187
[7]  Nie, S. and Ge, Y. (2023) The Link between the Gut Microbiome, Inflammation, and Parkinson’s Disease. Applied Microbiology and Biotechnology, 107, 6737-6749.
https://doi.org/10.1007/s00253-023-12789-6
[8]  黄彦玮, 曾开泰, 温子琪, 等. 帕金森病的肠道菌群标志物研究进展[J]. 实用医学杂志, 2024, 40(11): 1473-1478.
[9]  Aho, V.T.E., Houser, M.C., Pereira, P.A.B., Chang, J., Rudi, K., Paulin, L., et al. (2021) Relationships of Gut Microbiota, Short-Chain Fatty Acids, Inflammation, and the Gut Barrier in Parkinson’s Disease. Molecular Neurodegeneration, 16, Article No. 6.
https://doi.org/10.1186/s13024-021-00427-6
[10]  Agirman, G., Yu, K.B. and Hsiao, E.Y. (2021) Signaling Inflammation across the Gut-Brain Axis. Science, 374, 1087-1092.
https://doi.org/10.1126/science.abi6087
[11]  Zhang, X., Tang, B. and Guo, J. (2023) Parkinson’s Disease and Gut Microbiota: From Clinical to Mechanistic and Therapeutic Studies. Translational Neurodegeneration, 12, Article No. 59.
https://doi.org/10.1186/s40035-023-00392-8
[12]  Jia, X., Chen, Q., Zhang, Y. and Asakawa, T. (2023) Multidirectional Associations between the Gut Microbiota and Parkinson’s Disease, Updated Information from the Perspectives of Humoral Pathway, Cellular Immune Pathway and Neuronal Pathway. Frontiers in Cellular and Infection Microbiology, 13, Article 1296713.
https://doi.org/10.3389/fcimb.2023.1296713
[13]  Wu, S., Yang, L., Fu, Y., Liao, Z., Cai, D. and Liu, Z. (2024) Intestinal Barrier Function and Neurodegenerative Disease. CNS & Neurological DisordersDrug Targets, 23, 1134-1142.
https://doi.org/10.2174/0118715273264097231116103948
[14]  Mayer, E.A. (2011) Gut Feelings: The Emerging Biology of Gut-Brain Communication. Nature Reviews Neuroscience, 12, 453-466.
https://doi.org/10.1038/nrn3071
[15]  Kim, N., Yun, M., Oh, Y.J. and Choi, H. (2018) Mind-Altering with the Gut: Modulation of the Gut-Brain Axis with Probiotics. Journal of Microbiology, 56, 172-182.
https://doi.org/10.1007/s12275-018-8032-4
[16]  Ejtahed, H., Soroush, A., Angoorani, P., Larijani, B. and Hasani-Ranjbar, S. (2016) Gut Microbiota as a Target in the Pathogenesis of Metabolic Disorders: A New Approach to Novel Therapeutic Agents. Hormone and Metabolic Research, 48, 349-358.
https://doi.org/10.1055/s-0042-107792
[17]  Rea, K., Dinan, T.G. and Cryan, J.F. (2016) The Microbiome: A Key Regulator of Stress and Neuroinflammation. Neurobiology of Stress, 4, 23-33.
https://doi.org/10.1016/j.ynstr.2016.03.001
[18]  Sampson, T.R., Debelius, J.W., Thron, T., Janssen, S., Shastri, G.G., Ilhan, Z.E., et al. (2016) Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease. Cell, 167, 1469-1480.e12.
https://doi.org/10.1016/j.cell.2016.11.018
[19]  Kamada, N., Seo, S., Chen, G.Y. and Núñez, G. (2013) Role of the Gut Microbiota in Immunity and Inflammatory Disease. Nature Reviews Immunology, 13, 321-335.
https://doi.org/10.1038/nri3430
[20]  Lubomski, M., Xu, X., Holmes, A.J., Muller, S., Yang, J.Y.H., Davis, R.L., et al. (2022) The Gut Microbiome in Parkinson’s Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies. Frontiers in Aging Neuroscience, 14, Article 875261.
https://doi.org/10.3389/fnagi.2022.875261
[21]  van IJzendoorn, S.C.D. and Derkinderen, P. (2019) The Intestinal Barrier in Parkinson’s Disease: Current State of Knowledge. Journal of Parkinsons Disease, 9, S323-S329.
https://doi.org/10.3233/jpd-191707
[22]  Linh, H.T., Iwata, Y., Senda, Y., Sakai-Takemori, Y., Nakade, Y., Oshima, M., et al. (2022) Intestinal Bacterial Translocation Contributes to Diabetic Kidney Disease. Journal of the American Society of Nephrology, 33, 1105-1119.
https://doi.org/10.1681/asn.2021060843
[23]  Rolli-Derkinderen, M., Leclair-Visonneau, L., Bourreille, A., Coron, E., Neunlist, M. and Derkinderen, P. (2019) Is Parkinson’s Disease a Chronic Low-Grade Inflammatory Bowel Disease? Journal of Neurology, 267, 2207-2213.
https://doi.org/10.1007/s00415-019-09321-0
[24]  Chapelet, G., Leclair-Visonneau, L., Clairembault, T., Neunlist, M. and Derkinderen, P. (2019) Can the Gut Be the Missing Piece in Uncovering PD Pathogenesis? Parkinsonism & Related Disorders, 59, 26-31.
https://doi.org/10.1016/j.parkreldis.2018.11.014
[25]  Kishimoto, Y., Zhu, W., Hosoda, W., Sen, J.M. and Mattson, M.P. (2019) Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant Mice. NeuroMolecular Medicine, 21, 239-249.
https://doi.org/10.1007/s12017-019-08539-5

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133